menaquinone-7/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
menaquinone-7 — decreases serum undercarboxylated osteocalcin concentration
Evidence strength: very limited.Finding“Undercarboxylated osteocalcin concentrations decreased significantly, and the carboxylated osteocalcin/undercarboxylated osteocalcin ratio increased significantly in the 100 μg menaquinone-7 group compared with the placebo group (Study 2).”
Quoted verbatim from Low-Dose Daily Intake of Vitamin K(2) (Menaquinone-7) Improves Osteocalcin γ-Carboxylation: A Double-Blind, Randomized Controlled Trials.. - Study
- RCT
- Duration
- 3 months
- Dose
- 100 μg menaquinone-7 daily for 12 weeks
- Population
- Study 2: 120 healthy subjects aged 20-69 y, 100 μg/d menaquinone-7 versus placebo for 12 weeks
Low-Dose Daily Intake of Vitamin K(2) (Menaquinone-7) Improves Osteocalcin γ-Carboxylation: A Double-Blind, Randomized Controlled Trials.2015PMID:2687548910.3177/jnsv.61.471Permalink
To cite this finding: https://catalystproject.ai/e/01M5JC7ZWZK36CXQZFN51KH43Q